U.S. markets close in 4 hours 20 minutes
  • S&P 500

    3,822.20
    +0.65 (+0.02%)
     
  • Dow 30

    31,039.23
    +92.24 (+0.30%)
     
  • Nasdaq

    11,184.43
    +2.89 (+0.03%)
     
  • Russell 2000

    1,704.73
    -34.11 (-1.96%)
     
  • Crude Oil

    112.13
    +0.37 (+0.33%)
     
  • Gold

    1,818.00
    -3.20 (-0.18%)
     
  • Silver

    20.66
    -0.21 (-1.02%)
     
  • EUR/USD

    1.0473
    -0.0052 (-0.49%)
     
  • 10-Yr Bond

    3.1060
    -0.1000 (-3.12%)
     
  • GBP/USD

    1.2127
    -0.0058 (-0.47%)
     
  • USD/JPY

    136.7020
    +0.5740 (+0.42%)
     
  • BTC-USD

    20,062.95
    -642.05 (-3.10%)
     
  • CMC Crypto 200

    432.83
    -6.83 (-1.55%)
     
  • FTSE 100

    7,314.30
    -9.11 (-0.12%)
     
  • Nikkei 225

    26,804.60
    -244.87 (-0.91%)
     

Why 23andMe Stock Was Lagging the Market Today

·2 min read
Why 23andMe Stock Was Lagging the Market Today
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

The stock market was experiencing a frothy Friday on the last trading day of the week, but 23andMe Holding (NASDAQ: ME) was a bit of a wallflower at the party. As of 1:30 p.m. ET , the genetic testing and research specialist's shares were up only incrementally, at a rate well behind the S&P 500 index's 1.7% gain. For 23andMe's fourth quarter of fiscal 2022, the company recorded just under $101 million in revenue, which was 14% higher than the same period of the previous year.